Abiopharma

New Form 8-K - CARDINAL HEALTH INC Filed: 2025-08-12 AccNo: 0000721371-25-000075 Size: 915 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Cardinal Health Reports Fourth Quarter and Fiscal Year 2025 Results and Raises Fiscal Year 2026 Guidance

New Form 10-Q - Neuraxis, INC Filed: 2025-08-12 AccNo: 0001641172-25-023100 Size: 7 MB

New Form 10-Q - Liquidia Corp Filed: 2025-08-12 AccNo: 0001558370-25-011139 Size: 10 MB

argenx and Tennis Legend Monica Seles Team Up to Raise Awareness of Myasthenia Gravis

Cardinal Health announces the addition of Solaris Health, the countrys leading urology MSO, to The Specialty Alliance

New Form 6-K - Haleon plc Filed: 2025-08-12 AccNo: 0001654954-25-009386 Size: 83 KB

New Form 8-K - RAPID MICRO BIOSYSTEMS, INC. Filed: 2025-08-12 AccNo: 0001380106-25-000169 Size: 299 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant …

DarioHealth Reports Second Quarter 2025 Financial and Operating Results

New Form 8-K - Liquidia Corp Filed: 2025-08-12 AccNo: 0001104659-25-076412 Size: 256 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results

Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress

Zomedicas Fourth Friday at Four Webinar Returns: Spotlight on the VETIGEL(R) Hemostatic Product - The Future of Rapid Bleeding Control in Veterinary Medicine

Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.

DarioHealth Reports Second Quarter 2025 Financial and Operating Results